Astellas and XenoPort Announce Approval of Regnite® Tablets for Restless Legs Syndrome in Japan

January 18, 2012 | NEWS

TOKYO & SANTA CLARA, Calif.–(BUSINESSWIRE)– Astellas Pharma Inc. (Tokyo:4503) and XenoPort, Inc. (NASDAQ:XNPT – News) announced today that Regnite® (gabapentin enacarbil) has received marketing approval in …
(read the story…)

Tags: , , , , ,